The relative rise in Hb levels was indistinguishable between these groups during the initial phase of active treatment and transfusion management; however, while it continued to rise in those without SCA it then stalled in the SCA groups as they reached their baseline values. The gene discussed is GSTM1; the disease is autosomal dominant cerebellar ataxia.